Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995

Journal of Medical Genetics

Volumn 36, Issue 2, 1999, Pages 103-107

  Tulinius, Hrafn ^a,b   Sigvaldason, Helgi ^a   Ólafsdótti, Guriur ^a   Tryggvadóttir, Laufey ^a   Bjarnadóttir, Kristin ^a  

^a ICELANDIC CANCER REGISTRY   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Breast cancer; Incidence

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; FAMILIAL CANCER; FEMALE; HUMAN; ICELAND; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELATIVE; TIME;

AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; ICELAND; INCIDENCE; PEDIGREE; RISK FACTORS;

EID: 0032991784     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bjarnason Ó, Day N, Snædal G, Tulinius H. The effect of year of birth on the breast cancer age-incidence curve in Iceland. Int J Cancer 1974;13:689-96.
2. Tulinius H, Sigvaldason H, Ólafsdóttir G, Tryggvadóttir L. Epidemiology of breast cancer in families in Iceland. J Med Genet 1992;29:158-64.
3. Tulinius H, Egilsson V, Ólafsdóttir GH, Sigvaldason H. Risk of prostate, ovarian and endometrial cancer among relatives of breast cancer patients. BMJ 1992;305:855-7.
4. Tulinius H, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Bjarnadottir K. Neoplastic diseases in families of breast cancer patients. J Med Genet 1994;31:618-21.
5. Source: Statistics, Iceland.
6. Statistical Yearbook of Iceland 1996. Statistics Iceland III, Reykjavik, 1996, 39.
7. Snædal G. Cancer of the breast. Acta Chir Scand 1964;suppl 338:1-100.
8. Tulinius H, Bjarnason O, Sigvaldason H, Bjarnadottir G, Olafsdottir G. Tumours in Iceland. 10. Malignant tumours of the female breast. A histological classification, laterality, survival and epidemiological consideration. APMIS 1988; 96:229-38.
9. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Department of Public Health, Tohoku University School of Medicine, Sendai, Japan, 1960.
10. Gebski V, Leung O, McNeil D, Lunn D. SPIDA users' manual. Version 6. Statistical Computing Laboratory, Macquarie University, NSW, Australia, 1992.
11. Tulinius H, Sigvaldason H. Trends in incidence of female breast cancer in the Nordic countries, In: Magnus K, ed. Trends in cancer incidence. Washington: Hemisphere Publishing Corporation, 1982:235-47.
12. Hakulinen T, Andersen AA, Malker B, Pukkala E, Schou G, Tulinius H. Trends in cancer incidence in the Nordic countries. Acta Pathol Microbiol Immunol Scand 1986; section A:94.
13. Tulinius H, Storm HH, Pukkala E, Andersen A, Ericsson J. Cancer in the Nordic countries 1981-86. A joint publication of the five Nordic Cancer Registries. APMIS 1992; 100(suppl 31):1-194.
14. Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer incidence in the Nordic countries. APMIS 1993; 101(suppl 38):1-124.
15. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC Scientific Publications No 121. International Agency for Research on Cancer, Lyon, 1993.
16. Tulinius H, Sigvaldason H, Hrafhkelsson J, Ólafsdóttir G, Tryggvadóttir L, Sigur∂sson K. Reproductive factors and breast cancer risk in Iceland. A second cohort study. Int J Cancer 1990;46:972-5.
17. Ewertz M, Duffy SW, Adami H, et al. Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer 1990;46:597-603. .
18. Thorlacius S, Sigurdsson S, Bjarnadottir H, et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 1997;60:1079-84.
19. Johannesdottir G, Gudmundsson J, Bergthorsson JT, et al. High prevalence of the 999del5 mutation in Icelandic breast and ovarian patients. Cancer Res 1996;56:3663-5.